|
|
||||||||


* Department of Pediatrics, Ruijin Hospital, Medical School, Shanghai Jiaotong University,
Shanghai Institute of Planned Parenthood Research, and
Shanghai Hypertension Institute, Ruijin Hospital, Medical School, Shanghai Jiaotong University, Shanghai, China
Heme oxygenase-1 (HO-1) has anti-inflammatory effects in asthma. CD4+CD25high regulatory T cells (Treg) are a potent immunoregulator that suppresses the immune response. We studied the effects of HO-1-mediated CD4+CD25high Treg on suppression of allergic airway inflammation by comparing mice treated with hemin, OVA, Sn-protoporphyrin (SnPP), and hemin plus SnPP. Airway responsiveness, airway eosinophil infiltration, the level of OVA-specific IgE, and the numbers of cells in general and eosinophils in particular in bronchial alveolar lavage fluid were lower in the hemin group than in the OVA, SnPP, and hemin plus SnPP groups. The expressions of HO-1 mRNA and protein in the lung were increased by repeated administrations of hemin and SnPP. However, the activity of HO-1 was highest in hemin mice. The percentage and suppressive function of CD4+CD25high Treg and the expression of Foxp3 mRNA were obviously enhanced after treatment with hemin. This increase was diminished by the administration of SnPP. The concentration of serum IL-10 was higher in the hemin group than in the other groups, whereas the level of serum TGF-
did not significantly differ across groups. Furthermore, the ratio of IFN-
/IL-4 mRNA in the lung was higher in hemin-treated mice than in OVA and SnPP mice. The suppressive capacity of CD4+CD25high Treg was not enhanced in the IL-10-deficient mice treated with hemin. In conclusion, our experiments in the animal model demonstrated that HO-1 has anti-inflammatory effects, probably via enhancement of the secretion of IL-10 and promotion of the percentage of CD4+CD25high Treg.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the National Natural Science Foundation of China (30170988, 30570798), Shanghai Municipal Science and Technology Commission Foundation (044119662), and Shanghai Municipal Education Commission Foundation (03BZ04).
2 Address correspondence and reprint requests to Dr. Zhen-Wei Xia, Department of Pediatrics, Ruijin Hospital, Ruijin 2nd Road 197, Shanghai 200025, China. E-mail address: xzw63{at}hotmail.com
3 Z.-W.X. and W.-W.Z. contributed equally to this work.
4 Abbreviations used in this paper: HO, heme oxygenase; AHR, airway hyperreactivity; Treg, regulatory T cell; SnPP, Sn-protoporphyrin; BALF, bronchoalveolar lavage fluid; AR, airway responsiveness; Ach, acetylcholine; APTI, airway pressure time index; FW, forward primer; RV, reverse primer.
This article has been cited by other articles:
![]() |
T. Chang, L. Wu, and R. Wang Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H999 - H1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Lee, W. Gao, S. Mazzola, M. N. Thomas, E. Csizmadia, L. E Otterbein, F. H. Bach, and H. Wang Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells FASEB J, November 1, 2007; 21(13): 3450 - 3457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |